10.4
Silo Pharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
11.6
FY23:
7.68
FY24:
7.11
FY25:
7.39
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.09
FY22:
0.07
FY23:
0.06
FY24:
0.30
FY25:
0.22
Total assets
Change from FY21 to FY25
millions USD
FY21:
10.5
FY22:
11.6
FY23:
7.75
FY24:
7.41
FY25:
7.61
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.49
FY22:
0.44
FY23:
0.78
FY24:
1.66
FY25:
0.65
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.94
FY22:
0.87
FY23:
0.79
FY24:
0.72
FY25:
0.65
(positive)
Change from FY21 to FY25
millions USD
FY21:
9.06
FY22:
10.3
FY23:
6.18
FY24:
5.03
FY25:
6.31
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
10.5
FY22:
11.6
FY23:
7.75
FY24:
7.41
FY25:
7.61
All amounts in millions USD